Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Ikegami

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Comparative Neurology|September 18, 2009
Localization of circadian clock protein BMAL1 in the photoperiodic signal transduction machinery in Japanese quailKeisuke Ikegami, Yasuhiro Katou, Kumiko Higashi, et al.
Npj Biological Timing and Sleep|July 6, 2026
Additive framework of hormonal waves accounts for species and age differences in circadian intraocular pressure rhythmKeisuke Ikegami, Ryo Fujie, Fumito Mori, et al.
Nature Reviews. Endocrinology|August 14, 2019
Interconnection between circadian clocks and thyroid functionKeisuke Ikegami, Samuel Refetoff, Eve Van Cauter, et al.
Maturitas|January 7, 2025
Exploration of factors affecting denosumab-induced hypocalcemia in male patients with osteoporosis using a hospital-based administrative claims databaseYuto Kamimura, Keisuke Ikegami, Hayato Kizaki, et al.
Cancer Reports (Hoboken, N.J.)|May 3, 2025
Incidence Status and Factors Associated With Tyrosine Kinase Inhibitor-Induced Hypertension in Patients With Renal Cell CarcinomaSatoru Nakanishi, Keisuke Ikegami, Shungo Imai, et al.
Journal of Clinical Pharmacology|September 22, 2023
A Survey of the Status of Methadone Switching in Japan Using a Hospital-Based Administrative Claims DatabaseShungo Imai, Natsumi Aoki, Keisuke Ikegami, et al.
Journal of Clinical Pharmacology|April 6, 2022
Development of Risk Prediction Model for Grade 2 or Higher Hypocalcemia in Patients With Bone Metastasis Treated With Denosumab Plus Cholecalciferol (Vitamin D<sub>3</sub> )/Calcium SupplementKeisuke Ikegami, Masayuki Hashiguchi, Hayato Kizaki, et al.
Biochemical and Biophysical Research Communications|August 19, 2020
cAMP response element induces Per1 in vivoKeisuke Ikegami, Masato Nakajima, Yoichi Minami, et al.
The European Journal of Neuroscience|October 7, 2025
Circasemidian, Circadian, and Longer-Period Activity Rhythms in Caffeine-Treated Molecular Clock Deficient Cryptochrome (Cry) 1 and Cry 2 Double Knockout MiceSatoru Masubuchi, Takako Yano, Kouji Komatsu, et al.
Biological & Pharmaceutical Bulletin|January 3, 2023
Investigation of Prescription Status and Exploration of Risk Factors Related to Denosumab-Induced Hypocalcemia in Combination Therapy with 1α,25-Dihydroxy-vitamin D<sub>3</sub>Keisuke Ikegami, Megumi Saito, Shungo Imai, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Comparative Neurology|September 18, 2009
Localization of circadian clock protein BMAL1 in the photoperiodic signal transduction machinery in Japanese quailKeisuke Ikegami, Yasuhiro Katou, Kumiko Higashi, et al.
Npj Biological Timing and Sleep|July 6, 2026
Additive framework of hormonal waves accounts for species and age differences in circadian intraocular pressure rhythmKeisuke Ikegami, Ryo Fujie, Fumito Mori, et al.
Nature Reviews. Endocrinology|August 14, 2019
Interconnection between circadian clocks and thyroid functionKeisuke Ikegami, Samuel Refetoff, Eve Van Cauter, et al.
Maturitas|January 7, 2025
Exploration of factors affecting denosumab-induced hypocalcemia in male patients with osteoporosis using a hospital-based administrative claims databaseYuto Kamimura, Keisuke Ikegami, Hayato Kizaki, et al.
Cancer Reports (Hoboken, N.J.)|May 3, 2025
Incidence Status and Factors Associated With Tyrosine Kinase Inhibitor-Induced Hypertension in Patients With Renal Cell CarcinomaSatoru Nakanishi, Keisuke Ikegami, Shungo Imai, et al.
Journal of Clinical Pharmacology|September 22, 2023
A Survey of the Status of Methadone Switching in Japan Using a Hospital-Based Administrative Claims DatabaseShungo Imai, Natsumi Aoki, Keisuke Ikegami, et al.
Journal of Clinical Pharmacology|April 6, 2022
Development of Risk Prediction Model for Grade 2 or Higher Hypocalcemia in Patients With Bone Metastasis Treated With Denosumab Plus Cholecalciferol (Vitamin D<sub>3</sub> )/Calcium SupplementKeisuke Ikegami, Masayuki Hashiguchi, Hayato Kizaki, et al.
Biochemical and Biophysical Research Communications|August 19, 2020
cAMP response element induces Per1 in vivoKeisuke Ikegami, Masato Nakajima, Yoichi Minami, et al.
The European Journal of Neuroscience|October 7, 2025
Circasemidian, Circadian, and Longer-Period Activity Rhythms in Caffeine-Treated Molecular Clock Deficient Cryptochrome (Cry) 1 and Cry 2 Double Knockout MiceSatoru Masubuchi, Takako Yano, Kouji Komatsu, et al.
Biological & Pharmaceutical Bulletin|January 3, 2023
Investigation of Prescription Status and Exploration of Risk Factors Related to Denosumab-Induced Hypocalcemia in Combination Therapy with 1α,25-Dihydroxy-vitamin D<sub>3</sub>Keisuke Ikegami, Megumi Saito, Shungo Imai, et al.
Pageof 5